Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system

被引:61
|
作者
Szot, Patricia [1 ,2 ]
机构
[1] Vet Adm Puget Sound Hlth Care Syst, NW Network Mental Illness Res Educ & Clin Ctr, Seattle, WA USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
关键词
Alzheimer's disease; Parkinson's disease; Temporal lobe epilepsy; Locus coeruleus; Noradrenergic; Hippocampus; LOCUS-COERULEUS NEURONS; SUBSTANTIA-NIGRA; EFFERENT PROJECTIONS; DEPRESSION; DEMENTIA; CERULEUS; NOREPINEPHRINE; PATHOPHYSIOLOGY; SUBPOPULATIONS; SUSCEPTIBILITY;
D O I
10.1111/j.1528-1167.2012.03476.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurodegenerative disorders Alzheimers disease (AD) and Parkinsons disease (PD) share in common the neuropathologic loss of locus coeruleus (LC) noradrenergic neurons. In addition, these two neurodegenerative disorders share two symptoms that define these disorders: cognitive impairment and depression. The hippocampus is a region that is known to play a role in cognition and depression, and the hippocampus receives sole noradrenergic innervation from LC neurons. However, it is unclear how the loss of LC noradrenergic neurons contributes to these common symptoms in these two disorders. Epilepsy is not considered a neurodegenerative disorder, but the hippocampus is severely affected in temporal lobe epilepsy. Of interest, cognitive impairment and depression are also common comorbid disorders in temporal lobe epilepsy. This article describes common symptoms among these three neurologic disorders and a possible role of the noradrenergic nervous system.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [21] Common microRNA regulated pathways in Alzheimer's and Parkinson's disease
    Awuson-David, Betina
    Williams, Adrian C.
    Wright, Benjamin
    Hill, Lisa J.
    Di Pietro, Valentina
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [22] Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin
    Tchekalarova, Jana
    Tzoneva, Rumiana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [23] Parkinson's and Alzheimer's disease: The surprising role of stress
    Rosch, PJ
    STRESS MEDICINE, 1999, 15 (01): : 1 - 8
  • [24] Molecular Imaging of the Noradrenergic System in Idiopathic Parkinson's Disease
    Nahimi, Adjmal
    Kinnerup, Martin B.
    Sommerauer, Michael
    Gjedde, Albert
    Borghammer, Per
    IMAGING IN MOVEMENT DISORDERS: IMAGING METHODOLOGY AND APPLICATIONS IN PARKINSON'S DISEASE, 2018, 141 : 251 - 274
  • [26] Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease
    Soloway, Albert H.
    Soloway, Paul D.
    Warner, Victor D.
    MEDICAL HYPOTHESES, 2013, 81 (04) : 690 - 694
  • [27] Is it possible to differentiate Alzheimer's disease from Parkinson's disease dementia by praxis tests?
    Sanli, Zeynep Selcan
    Evlice, Ahmet
    Binokay, Hulya
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2023, 36 (04): : 222 - 229
  • [28] Iron in Alzheimer's disease and Parkinson's disease
    Bush, A.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 5 - 5
  • [29] Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease?
    Levy, G
    Tang, MX
    Cote, LJ
    Louis, ED
    Alfaro, B
    Mejia, H
    Stern, Y
    Marder, K
    NEUROLOGY, 2001, 56 (08) : A222 - A223
  • [30] Metallostasis in Alzheimer's disease and Parkinson's disease
    Bush, A., I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S27 - S27